Michael Chuong, Vice Chair and Medical Director of the Department of Radiation Oncology at Miami Cancer Institute, GI Section Editor at International Journal Radiation Oncology, Biology, Physics and Professor at FIU Herbert Wertheim College of Medicine, shared a post on LinkedIn:
“Humbled to be the first credentialed in the United States to prescribe Novocure Optune Pax for pancreatic cancer
I’m especially excited for our patients at Baptist Health Miami Cancer Institute who will benefit from Tumor Treating Fields as shown in the positive phase 3 PANOVA-3 trial.
We are making progress.”
Other articles featuring Michael Chuong on Oncodaily.